Fathima Shehnaz Ayoobkhan
Fathima Shehnaz Ayoobkhan publishes mostly in Cardiology and Cardiovascular Medicine, Surgery and Pulmonary and Respiratory Medicine, on topics such as Cardiac Valve Diseases and Treatments, CAR-T cell therapy research and Mechanical Circulatory Support Devices.
- World rank
- #4,701,539 of 7,710,434 ranked researchers
- Rank in United States
- #1,238,270 of 1,627,098
- Works
- 91
- Citations
- 73
- Citations per work
- 0.8
What does Fathima Shehnaz Ayoobkhan research?
Fathima Shehnaz Ayoobkhan's work is mostly in Medicine (54%), Immunology and Microbiology (5%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences5054.5%
- Medicine5054.5%
- Everything else3740.6%
- Life Sciences44.9%
- 1Cardiology and Cardiovascular Medicine24% of their works
- 2Surgery8% of their works
- 3Pulmonary and Respiratory Medicine8% of their works
- 4Hematology7% of their works
- 5Oncology7% of their works
- 6Immunology5% of their works
Research topics
- Cardiac Valve Diseases and Treatments
- CAR-T cell therapy research
- Mechanical Circulatory Support Devices
- Multiple Myeloma Research and Treatments
- Immunodeficiency and Autoimmune Disorders
- Cardiac pacing and defibrillation studies
- Economic and Financial Impacts of Cancer
- Atrial Fibrillation Management and Outcomes
Which keywords describe Fathima Shehnaz Ayoobkhan's research?
The keywords of their largest research topics: Heart Failure, Surgical Aortic-Valve Replacement, Transcatheter Aortic-Valve Replacement, CAR T Cells, Chimeric Antigen Receptor, Extracorporeal Membrane Oxygenation, Left Ventricular Assist Device and Diagnosis Criteria.
- Anticoagulant Therapy
- Implantable Cardioverter-Defibrillator
- Financial Toxicity
- Cardiac Resynchronization Therapy
- Diagnosis Criteria
- Extracorporeal Membrane Oxygenation
- CAR T Cells
- Surgical Aortic-Valve Replacement
- Heart Failure
- Transcatheter Aortic-Valve Replacement
- Chimeric Antigen Receptor
- Left Ventricular Assist Device
- International Myeloma Working Group
- Cost of Care
- Genetic Mutations
- Primary Immunodeficiency
- Atrial Fibrillation
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 17 words, with their numbers
- Heart Failure132 topics
- Surgical Aortic-Valve Replacement111 topic
- Transcatheter Aortic-Valve Replacement111 topic
- CAR T Cells91 topic
- Chimeric Antigen Receptor91 topic
- Extracorporeal Membrane Oxygenation81 topic
- Left Ventricular Assist Device81 topic
- Diagnosis Criteria61 topic
- International Myeloma Working Group61 topic
- Cardiac Resynchronization Therapy51 topic
- Cost of Care51 topic
- Financial Toxicity51 topic
- Genetic Mutations51 topic
- Implantable Cardioverter-Defibrillator51 topic
- Primary Immunodeficiency51 topic
- Anticoagulant Therapy41 topic
- Atrial Fibrillation41 topic
Where does Fathima Shehnaz Ayoobkhan work?
Fathima Shehnaz Ayoobkhan's main affiliation in the publication record is Trinity Health, United States.
How many publications and citations does Fathima Shehnaz Ayoobkhan have?
OpenAlex counts 91 works and 73 citations for Fathima Shehnaz Ayoobkhan, an h-index of 5, ranking #4,701,539 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Fathima Shehnaz Ayoobkhan. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.